Genmab — Juni 2019

[Hen]

Investtech-analysevideo fra i går: https://play.borsen.dk/klip/5d073ad3595ab4f00a333654

[E_L]

yes, he also said 'it won't be as quickly as daratumumab obviously', not sure why. Anyway, currently the speed is 1 of Isa's few advantages; that will disappear with Dara SC

[E_L]

it is funny how these doctors speak as if it is already approved sometimes... ("now that we have SC"...)

[E_L]

i also thought it was interesting them talking about Dara monthly maintenance possibly switching back to weekly in case of deterioration

[Bulder]

Maybe they already started off label .- it's not a new drug, only way of adm.

[E_L]

yes, maybe. Rajkumar sort of seemed to imply that also with D-VRd and D-VTd. Will be interesting to see US volume later this year...

[LyngeInv]

Fra Medwatch: Det tyske biotekselskab Biontech er sammen med Genmab klar til det første forsøg i mennesker med et lægemiddel, som de to selskaber udvikler i fællesskab.

[E_L]

another example of off-label? https://twitter.com/SchutzNatalia/status/1140976374464831488

[AaBforever]

Ser ud til det bliver en okay dag i dag..:-)

[Vitus]

Nå nå AaB....nu ikke for optimistisk ...vi er vel nordjyder

[Darvin]

Han skrev “okay” ikke god eller
super

[AaBforever]

God skal vi over 1300...super skal vi over 1400...:-D

[Vitus]

Enig AaB .....

[bibob]

Jow, det går da nogenlunde.

[Darvin]

Det er da et bette skridt på vejen - så det!

[Vitus]

Champagnen skal nok ikke på køl i dag

[AaBforever]

Næh...jeg nøjes med en håndbajer..;-)

[Vitus]

Måske vi kan håbe på en godnatpilsner....jeg tænker på hende Ma........

[transalp]

Hende skal vi ikk regne med, før vi ser hende, ustabil tøs, hende Ma..

[E_L]

i guess we will see this more and more, other companies starting studies with Dara as one of the 'Standard Treatments ' https://clinicaltrials.gov/ct2/show/NCT03989414?term=daratumumab+OR+ofatumumab+OR+tisotumab+OR+Genmab+OR+arzerra+OR+duobody&lupd_s=06%2F17%2F2019&rank=2